Beyond antipsychotic efficacy and toward an individualized therapeutic strategy: analysis of the systemic, metabolic, and inflammatory effects of olanzapine, haloperidol, and their combination in schizophrenic patients
This study provides valuable insights into the systemic, metabolic, and inflammatory effects of tested drugs, support the individualized therapeutic approaches in schizophrenic patients to optimize clinical outcomes and minimizing long-term systemic risks.
Authors
- Nayef Samah Alharbi
- Noha Alaa Hamdy (ORCID: https://orcid.org/0000-0002-4606-8567)
- Ghaleb Alharbi (ORCID: https://orcid.org/0009-0005-4823-0731)
- Esam M. Aboubakr (ORCID: https://orcid.org/0000-0001-6309-847X)
- M. G. Alharbi
- Ahmed Ibrahim ElMallah
- Mostafa A. Ali
Institutions
- Qassim University (SA)
- South Valley University (EG)
- American Association of Colleges of Pharmacy (US)
- Shaqra University (SA)
- Ministry of Health (AE)
- Alexandria University (EG)
- Assiut University (EG)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.3389/fphar.2026.1727959
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00